+3 | The top 3 medtech stories for October 14, 2015

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. HeartFlow’s CT-based FFR lowers costs, improves quality of life A non-invasive test of cardiac function made by HeartFlow lowered the cost of care and delivered improved quality of life scores compared to standard care, according to a study presented at the annual Transcatheter Cardiovascular Therapeutics conference. HeartFlow’s FFRCT test uses data from a standard CT scan to create a 3D map of the changes in blood flow as it passes across a coronary lesion. Results from the 584-patient Platform trial showed that the costs associated with planned angiography and the FFRCT procedure were 32% lower than the cost of angiography alone ($7,343 vs. $10,734). Read more 2. SynCardia pulls $28m IPO SynCardia Systems withdrew its plans for an initial public offering that was slated to fetch $27.5 million at the midpoint. “The registrant submits this request for withdrawal as it does not intend to pursue the contemplated public offering at this time,” the Tucson-based artificial heart maker said in an SEC filing. Syncardia had planned to float 2.5 million shares at $10 to $12 apiece. Read more 1. AtriCure closes $99m n...
Source: Mass Device - Category: Medical Equipment Authors: Tags: News Well Plus 3 Source Type: news

Related Links:

ABSTRACT Get With The Guidelines ® – Stroke is an in-hospital program for improving stroke care by promoting adherence to scientific guidelines. Of the patients with transient ischemic attack (TIA), 10-15% have a stroke within three months, and many patients do not receive the recommended interventions to prevent this outcome. Objective: The goal of this study was to assess the adherence to stroke quality indicators in patients with TIA. Methods: This retrospective observational study evaluated consecutive patients admitted to a primary stroke center with TIA or acute ischemic stroke (AIS) from August 2008 to Dec...
Source: Arquivos de Neuro-Psiquiatria - Category: Neurology Source Type: research
Publication date: November 2018Source: Annals of Emergency Medicine, Volume 72, Issue 5Author(s): Cameron Gettel, Elizabeth M. Goldberg
Source: Annals of Emergency Medicine - Category: Emergency Medicine Source Type: research
Publication date: Available online 17 October 2018Source: Cor et VasaAuthor(s): Ersin Doğanözü, Ilker Sahin, Emir Karacaglar, Senem Has Hasırcı, Mehmet Zeki BuldanliAbstractAtrial fibrillation is the most common rhythm disorder worldwide. Oral anticoagulants are used in the treatment of atrial fibrillation. Non vitamin K oral anticoagulants have been used more often because of the fact that they are more effective and safer than conventional warfarin therapy. The absence of antidote in the majority of new generation oral anticoagulants leads to some difficulties in clinical usage. Idarucizumab, a recently intr...
Source: Cor et Vasa - Category: Cardiology Source Type: research
International Journal of Clinical Practice,Volume 0, Issue ja, -Not available-.
Source: International Journal of Clinical Practice - Category: Internal Medicine Authors: Source Type: research
Journal of Cardiovascular Electrophysiology, EarlyView.
Source: Journal of Cardiovascular Electrophysiology - Category: Cardiology Authors: Source Type: research
Handheld ECG recorders may have algorithms which automatically inform the user of presence of arrhythmia. The main objectives of this study were to evaluate the accuracy of the arrhythmia diagnosis algorithm of Beurer ME90 recorder to diagnose atrial fibrillation (AF)/flutter, and to evaluate whether recording technique (finger versus precordial) affects diagnostic performance.
Source: Journal of Electrocardiology - Category: Cardiology Authors: Source Type: research
mhealth’s SnapECG is a medical-grade handheld single-lead electrocardiograph that connects via Bluetooth to a smartphone. It gives a recording of the heart’s electrical pulses, and stores the data to be given to a doctor later. It has rec...
Source: Medgadget - Category: Medical Devices Authors: Tags: Cardiology Critical Care Emergency Medicine Exclusive Source Type: blogs
Source: BMJ Education - Category: General Medicine Source Type: research
We describe two different cases with very high overdosage in which PCC or idarucizumab was used to reverse the effect of dabigatran etexilate.
Source: Blood Coagulation and Fibrinolysis - Category: Hematology Tags: CASE REPORTS Source Type: research
Publication date: Available online 16 October 2018Source: Journal of Clinical NeuroscienceAuthor(s): Shengbang Zheng, Baodong YaoAbstractRisk factors for first-ever stroke have been studied extensively, while those for recurrent stroke are not accurately understood. To provide the adequate secondary prevention for the patients, it is necessary to reveal the risk factors that dominate recurrent stroke. Multiple databases were adopted to search for the relevant studies and full-text articles involving in the risk factors for stroke recurrence were reviewed. Meta-analyses were performed with Review Manager 5.0 to estimate the...
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
More News: Angiography | Atrial Fibrillation | Cardiology | Cardiovascular | Conferences | CT Scan | Health | Heart | Heart Transplant | Medical Devices | Perfusion | PET Scan | Study